Is Hutchison China MediTech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Hutchison China MediTech 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was GBP351.00, you would have made a loss of GBP-89.00 per share or -25.36%
Yes, the average daily trading liquidity for Hutchison China MediTech is GBP75 825 thousand. You should therefore be able to get in and out of your positions relatively fast.
Hutchison China MediTech has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 2.55, the company's ability to pay off the debt is good. Hutchison China MediTech has a good net profit margin of 12.03% and should have high tolerances against inflation.
We have calculated the inflation risk for Hutchison China MediTech to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.